Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-11 Sale | 2026-03-13 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 2,633 | $498.42 | $1,312,340 | 12,489 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 2,437 | $475.3 | $1,158,306 | 15,122 (Direct) | View |
| 2026-02-25 Sale | 2026-02-26 6:48 pm | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 4,910 | $487.65 | $2,394,365 | 17,559 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-24 Tax Withholding | 2026-02-26 6:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 873 | $485.11 | 17,559 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 4,962 | $0 | 23,342 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 1,148 | $483.75 | 23,342 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:37 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 2,283 | $487.76 | 19,528 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 5:04 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 1,127 | $468.41 | 21,811 (Direct) | View |
| 2026-01-22 Option Award | 2026-01-26 4:30 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 6,800 | $0 | 22,938 (Direct) | View |
Ownership | 2025-07-02 4:20 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | McKechnie Duncan EVP, Chief Commercial Officer | 0 | $0 | 16,130 (Direct) | View |